Yemen on Saturday launched a 25-day campaign aimed at controlling the spread of malaria in the Hajja, Hodeidah and Saada provinces as part of its efforts to eradicate the disease by 2015, the Organization of Asia-Pacific News Agencies reports.
The campaign will target about 134,000 houses in 17 districts in the three provinces, Majid al-Junaid, undersecretary of public health and population, said. Al-Junaid added that malaria is one of the government's highest health priorities.
Malaria
Malaria is caused by a parasite that enters blood through the bite of an infected mosquito. It is characterized by fever, vomiting, shivering, sweating and other symptoms.
Advertisement
Approximately 60% of Yemen's population is at risk of contracting malaria, according to data from the World Health Organization. There are more than 700,000 cases of malaria reported annually in the country, and there are about 15,000 deaths from the disease each year, according to WHO and the Ministry of Public Health and Population.
Source: Kaiser Family Foundation
SRM/C
SRM/C
Introducing New 'Hi Protection', 'Hi Safe' Malaria Vaccine
Tests affirm that the new malarial vaccine 'Mosquirix' rendered a high level of protection and safety.
Advertisement
The New Malaria Wonder VaccineThe vaccine efficacy is 65 pct for a three-month period and has a safety and tolerability profile. | Advertisement
|
Advertisement
Recommended Readings
Latest Tropical Disease News
Mumbai's TechInvention Lifecare and South Korean Eubiologics team up to introduce oral cholera vaccine in India after successful phase III clinical trial.
Scientists have found that the dengue virus has become more severe in India, highlighting the urgent need for vaccines that target the strains found in the country.
It is important to consider malarial infection in cases of acute kidney injury in someone with a travel history from endemic areas to improve treatment outcomes.
Ghana approves the use of the University of Oxford's malaria vaccine, produced by the Serum Institute of India (SII), becoming the first country to adopt the new vaccine.
The dengue virus combines molecules from its RNA with mosquito saliva to foil the human immune system and spread dengue fever and related diseases.